Pages that link to "Q74641505"
Jump to navigation
Jump to search
The following pages link to A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections (Q74641505):
Displaying 11 items.
- Potential interactions of the extended-spectrum fluoroquinolones with the CNS. (Q33717059) (← links)
- Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus (Q33978084) (← links)
- Once-daily oral gatifloxacin versus oral levofloxacin in treatment of uncomplicated skin and soft tissue infections: double-blind, multicenter, randomized study (Q33982775) (← links)
- A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections (Q34248416) (← links)
- Levofloxacin: an updated review of its use in the treatment of bacterial infections (Q34880958) (← links)
- Levofloxacin: a review of its use in the treatment of bacterial infections in the United States (Q35603775) (← links)
- The new fluoroquinolones: A critical review (Q35649595) (← links)
- Newer treatment options for skin and soft tissue infections (Q35838370) (← links)
- The Role of Fluoroquinolones in the Treatment of Skin and Soft Tissue Infection (Q48729366) (← links)
- Are Respiratory Quinolones Useful for the Treatment of Skin and Soft Tissue Infections? (Q51653710) (← links)
- Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract (Q77428146) (← links)